Vmak Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 2.00 K
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 67.96%
- Profit Growth -18.50%
- Ebitda 2.26%
- Net Worth 50.78%
- Total Assets 21.51%
About Vmak Healthcare India
Vmak Healthcare India Private Limited (VHIPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2016 (Eight years and ten months 19 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Makfirst Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.00 K , as per Ministry of Corporate Affairs (MCA) records.
Abhishek Jain and Ritesh Jain serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100MH2016PTC274284
- Company No.
274284
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vmak Healthcare India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Jain  | Director | 24-Sep-2018 | Current |
| Ritesh Jain | Director | 12-Sep-2018 | Current |
Financial Performance of Vmak Healthcare India.
Vmak Healthcare India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 67.96% increase. The company also saw a substantial fall in profitability, with a 18.5% decrease in profit. The company's net worth Soared by an impressive increase of 50.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vmak Healthcare India?
In 2019, Vmak Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Capricoating Solutions Private LimitedAbhishek Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vmak Healthcare India?
Unlock and access historical data on people associated with Vmak Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vmak Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vmak Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
